Unknown

Dataset Information

0

Bolstering the Number and Function of HSV-1-Specific CD8+ Effector Memory T Cells and Tissue-Resident Memory T Cells in Latently Infected Trigeminal Ganglia Reduces Recurrent Ocular Herpes Infection and Disease.


ABSTRACT: HSV type 1 (HSV-1) is a prevalent human pathogen that infects >3.72 billion individuals worldwide and can cause potentially blinding recurrent corneal herpetic disease. HSV-1 establishes latency within sensory neurons of trigeminal ganglia (TG), and TG-resident CD8+ T cells play a critical role in preventing its reactivation. The repertoire, phenotype, and function of protective CD8+ T cells are unknown. Bolstering the apparent feeble numbers of CD8+ T cells in TG remains a challenge for immunotherapeutic strategies. In this study, a comprehensive panel of 467 HLA-A*0201-restricted CD8+ T cell epitopes was predicted from the entire HSV-1 genome. CD8+ T cell responses to these genome-wide epitopes were compared in HSV-1-seropositive symptomatic individuals (with a history of numerous episodes of recurrent herpetic disease) and asymptomatic (ASYMP) individuals (who are infected but never experienced any recurrent herpetic disease). Frequent polyfunctional HSV-specific IFN-?+CD107a/b+CD44highCD62LlowCD8+ effector memory T cells were detected in ASYMP individuals and were primarily directed against three "ASYMP" epitopes. In contrast, symptomatic individuals have more monofunctional CD44highCD62LhighCD8+ central memory T cells. Furthermore, therapeutic immunization with an innovative prime/pull vaccine, based on priming with multiple ASYMP epitopes (prime) and neurotropic TG delivery of the T cell-attracting chemokine CXCL10 (pull), boosted the number and function of CD44highCD62LlowCD8+ effector memory T cells and CD103highCD8+ tissue-resident T cells in TG of latently infected HLA-A*0201-transgenic mice and reduced recurrent ocular herpes following UV-B-induced reactivation. These findings have profound implications in the development of T cell-based immunotherapeutic strategies to treat blinding recurrent herpes infection and disease.

SUBMITTER: Khan AA 

PROVIDER: S-EPMC5515716 | biostudies-literature | 2017 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Bolstering the Number and Function of HSV-1-Specific CD8<sup>+</sup> Effector Memory T Cells and Tissue-Resident Memory T Cells in Latently Infected Trigeminal Ganglia Reduces Recurrent Ocular Herpes Infection and Disease.

Khan Arif A AA   Srivastava Ruchi R   Chentoufi Aziz A AA   Kritzer Elizabeth E   Chilukuri Sravya S   Garg Sumit S   Yu David C DC   Vahed Hawa H   Huang Lei L   Syed Sabrina A SA   Furness Julie N JN   Tran Tien T TT   Anthony Nesburn B NB   McLaren Christine E CE   Sidney John J   Sette Alessandro A   Noelle Randolph J RJ   BenMohamed Lbachir L  

Journal of immunology (Baltimore, Md. : 1950) 20170524 1


HSV type 1 (HSV-1) is a prevalent human pathogen that infects >3.72 billion individuals worldwide and can cause potentially blinding recurrent corneal herpetic disease. HSV-1 establishes latency within sensory neurons of trigeminal ganglia (TG), and TG-resident CD8<sup>+</sup> T cells play a critical role in preventing its reactivation. The repertoire, phenotype, and function of protective CD8<sup>+</sup> T cells are unknown. Bolstering the apparent feeble numbers of CD8<sup>+</sup> T cells in T  ...[more]

Similar Datasets

| S-EPMC1805572 | biostudies-literature
| S-EPMC3744444 | biostudies-literature
| S-EPMC2753103 | biostudies-other
| S-EPMC7341572 | biostudies-literature
| S-EPMC4442501 | biostudies-literature
| S-EPMC10259006 | biostudies-literature
| S-EPMC2798372 | biostudies-literature
| S-EPMC5105190 | biostudies-literature
| S-EPMC6330031 | biostudies-literature
| S-EPMC4840408 | biostudies-literature